Results 1 -
10
of
25
for
Olaparib OR AZD2281
- Olaparib is used alone or in combination with bevacizumab (Avastin) to help maintain the response of certain ... responded to their first or later chemotherapy treatments. Olaparib is also used to treat certain types of ...
- Triple-Negative Breast Cancer (Living Beyond Breast Cancer)Breast Cancer/Specifics ... Breast Cancer ... Living Beyond Breast Cancer ... About 10% to 15% of breast cancers are triple-negative. Learn more about the symptoms, ...
- Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancers Treatment
(National Cancer Institute)
Ovarian Cancer/Specifics ... Ovarian Cancer ... National Cancer Institute ... From the National Institutes of Health ... Treatment of ovarian epithelial, fallopian tube, ... - Breast Cancer/Treatments and Therapies ... Breast Cancer ... National Cancer Institute ... From the National Institutes of Health ... This page lists cancer drugs approved ...
- Prostate Cancer/Treatments and Therapies ... Prostate Cancer ... National Cancer Institute ... From the National Institutes of Health ... This page lists cancer drugs approved ...
- Pancreatic Cancer/Treatments and Therapies ... Pancreatic Cancer ... National Cancer Institute ... From the National Institutes of Health ... This page lists cancer drugs ...
- Drugs Approved for Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
(National Cancer Institute)
Ovarian Cancer/Treatments and Therapies ... Ovarian Cancer ... National Cancer Institute ... From the National Institutes of Health ... This page lists cancer drugs approved ... - Breast Cancer/Treatments and Therapies ... Breast Cancer ... National Cancer Institute ... From the National Institutes of Health ... Breast cancer treatment depends on several ...
- Uterine Cancer/Statistics and Research ... Uterine Cancer ... National Cancer Institute ... From the National Institutes of Health ... An overview of what's new and recent ...
- Prostate Cancer/Statistics and Research ... Prostate Cancer ... National Cancer Institute ... From the National Institutes of Health ... Find what's new in prostate cancer ...